Literatur
- 1
Amant F, Moerman P, Neven P. et al .
Endometrial cancer.
Lancet.
2005;
366
491-505
- 2 Robert Koch Institut . www.rki.de.
- 3
Rackow B W, Arici A.
Endometrial cancer and fertility.
Curr Opin Obstet Gynecol.
2006;
18
245-252
- 4
Emons G, Fleckenstein G, Hinney B. et al .
Hormonal interactions in endometrial cancer.
Endocr Rel Cancer.
2000;
7
227-242
- 5
ACOG Committee on Practice Bulletins. Management of endometrial cancer .
ACOG Practice Bulletin, Clinical Management Guidelines for Obstetrician-Gynecologists.
Obstet Gynecol.
2005;
106
413-424
- 6
Schmeler K M, Lynch H T, Chen L. et al .
Prophylactic surgery to reduce the risk of gynecologic cancers in the lynch syndrome.
N Engl J Med.
2006;
354
261-269
- 7
Beral V, Bull D, Reeves G. Million Women Study Collaborators .
Endometrial cancer and hormone-replacement therapy in the Million Women Study.
Lancet.
2005;
365
1543-1551
- 8
Pothuri B, Ramondetta L, Eifel P. et al .
Radiation-associated endometrial cancers are prognostically unfavorable tumors: A
clinicopathologic comparison with 527 sporadic endometrial cancers.
Gynecol Oncol.
2006;
103
948-951
- 9
Trimble C L, Kauderer J, Zaino R. et al .
Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial
hyperplasia.
Cancer.
2006;
106
812-819
- 10 Emons G, Beckmann M W, Böing C. et al. für die Kommission Uterus der AGO .Endometriumkarzinom. In:
Kaufmann M, Beckmann MW, Emons G et al. (Hrsg). Aktuelle Empfehlungen der Arbeitsgemeinschaft
Gynäkologische Onkologie. Zuckschwert, München 2006; 179-195
- 11
Barwick T D, Rockall A G, Barton D P, Sohaib S A.
Imaging of endometrial adenocarcinoma.
Clin Radiol.
2006;
61
545-555
- 12
Montgomery B E, Daum G S, Dunton C J.
Endometrial hyperplasia: a review.
Obstet Gynecol Surv.
2004;
59
368-378
- 13
Emons G.
Endometrial cancer - suggestions for the update of the guidelines.
Zentralbl Gynakol.
2006;
128
18-22
- 14
Shaeffer D T, Randall M E.
Adjuvant radiotherapy in endometrial carcinoma.
The Oncologist.
2005;
10
623-631
- 15
Creutzberg C L, van Putten W LJ, Wárlám-Rodenhuis C C. et al .
Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma
patiens: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial.
J Clin Oncol.
2004;
22
1234-1241
- 16
Randall M E, Filiaci V L, Muss H. et al .
Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin
chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.
J Clin Oncol.
2006;
24
36-44
- 17
Greven K, Winter K, Underhill K. et al .
Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel
chemotherapy following surgery for patients with high-risk endometrial cancer.
Gynecol Oncol.
2006;
103
155-159
- 18 National Comprehensive Cancer Centre Network .Uterine Cancers. The complete library
of NCCN Clinical Practice Guidelines in Oncology. June 2006. www.nccn.org
- 19
van Wijk F H, Huikeshoven F J, Abdulkadir L. et al .
Stage III and IV endometrial cancer: a 20-year review of patients.
Int J Gynecol Cancer.
2006;
16
1648-1655
- 20
Havrilesky L J, Cragun J M, Calingaert B. et al .
Resection of lymph node metastases influences survival in stage III C endometrial
cancer.
Gynecol Oncol.
2005;
99
689-695
- 21
Ben-Shachar I, Pavelka J, Cohn D E. et al .
Surgical staging for patients presenting with grade 1 endometrial cancer.
Obstet Gynecol.
2005;
105
487-492
- 22
Frumovitz M, Slomovitz B M, Singh D K. et al .
Frozen section analyses as predictors of lymphatic spread in patients with early-stage
uterine cancer.
J Am Coll Surg.
2004;
199
388-393
- 23
Tozzi R, Malur S, Koehler C, Schneider A.
Laparoscopy versus laparotomy in endometrial cancer: first analysis of survival of
a randomized prospective study.
J Minim Invasive Gynecol.
2005;
12
130-136
- 24
Tozzi R, Malur S, Koehler C, Schneider A.
Analysis of morbidity in patients with endometrial cancer: is there a commitment to
offer laparoscopy?.
Gynecol Oncol.
2005;
97
4-9
- 25
Havrilesky L J, Cragun J M, Calingaert B. et al .
The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis
in stage IIIA endometrial cancer.
Gynecol Oncol.
2006;
, in press
- 26
Bristow R E, Santillan A, Zahurak M L. et al .
Salvage cytoreductive surgery for recurrent endometrial cancer.
Gynecol Oncol.
2006;
103
281-287
- 27
Carey M S, Gawlik C, Fung-Kee-Fung M. et al. on behalf of the Cancer Care Ontario
Practice Guidelines Initiative Gynecology Cancer Disease Site Group .
Systematic review of systemic therapy for advanced or recurrent endometrial cancer.
Gynecol Oncol.
2006;
101
158-167
- 28 Humber C, Tierney J, Symonds P. et al .Chemotherapy for advanced, recurrent or
metastatic endometrial carcinoma. The Cochrane Database of Systematic Reviews 2005;
Issue 4. Art. No.: CD003915.pub3. DOI: 10.1002/14651858.CD003915.pub3
- 29
Obel J C, Friberg G, Fleming G F.
Chemotherapy in endometrial cancer.
Clin Adv Hematol Oncol.
2006;
4
459-468
- 30
Fung-Kee-Fung M, Dodge J, Elit L. et al. on behalf of the Cancer Care Ontario Program
in Evidence-based Care Gynecology Cancer Disease Site Group .
Gynecol Oncol.
2006;
101
520-529
Prof. Dr. med. G. Emons
Klinik für Gynäkologie und Geburtshilfe · Georg-August-Universität Göttingen
Robert Koch-Str. 40
37075 Göttingen
Email: emons@med.uni-goettingen.de
